Breathing Machines Market
Dynamics
Increasing number of respiratory
disorders such as asthma and COPD, and rising number of surgeries are expected
to drive growth of the global Breathing
Machines Market. According to the National Institute of Health data of
2014, asthma affects over 24 million people in the U.S., including over 6
million children. Breathing problems can also occur due to serious conditions
such as pneumonia, tuberculosis, lung cancer, and other lung diseases. According
to the World Health Organization (WHO) estimates, by 2030, the four major
potentially fatal respiratory diseases including COPD, pneumonia, lung cancer,
and tuberculosis will account for around one in five deaths worldwide.
Millions of people in the U.S.
suffer from breathing problems such as chronic obstructive pulmonary disease
(COPD), which includes chronic bronchitis and emphysema. COPD is a progressive
life-threatening lung disease that causes breathlessness and predisposes to
exacerbations and serious illness. In 2016, the Global Burden of Disease
reported a prevalence of around 251 million cases of COPD worldwide. According
to the same source, a total of 3.17 million deaths occurred due to COPD in
2015, which account for 5% of all deaths globally. COPD prevalence is expected
to increase in the near future due to higher smoking prevalence and aging
populations in many economies worldwide.
However, few drawbacks of
breathing machines include throat discomfort, damage to vocal cords, and
sleeping discomfort. Some complications of using a breathing machine may
include lung damage, collapsed lung, pneumonia or infection. Moreover, constant
medical care is required when a breathing machine is used. These factors are
expected to hinder growth of the market.
* The sample copy includes: Report Summary, Table of
Contents, Segmentation, Competitive Landscape, Report Structure, Methodology.
Request a sample copy
of this report: https://www.coherentmarketinsights.com/insight/request-sample/2032
Breathing machine helps the
patient to breathe while they are suffering from chronic respiratory diseases
or unable to breathe by themselves after anesthesia. Breathing machines are
used during surgeries that require general anesthesia, as the medicines used to
induce anesthesia can disrupt normal breathing. The machine is required after
the surgery, as the patient may not be able to breathe immediately after the
procedure. The type of breathing machine used varies according to the problem.
Ventilators are mainly used in
emergency medicine, home care, intensive care medicine, and in anesthesia, as a
component of an anesthesia machine. The oxygen concentrator delivers pure
oxygen via a mask or nasal cannula. It may be used in hyperbaric chambers and
oxygen therapy. A C-PAP (continuous positive airway pressure) breathing machine
blows air into the nose through a mask, which in turn keeps the airway open and
helps in the absorption of oxygen.
Nebulizers are generally used for
the treatment of a range of respiratory disorders such as chronic obstructive
pulmonary disease (COPD) and asthma. Medications are inhaled straight into the
lungs for effective treatment. These machines aid people who suffer from asthma
by delivering liquid medication through a mist, which is inhaled into the lungs
via machine. These devices are majorly used in home care settings.
Browse Research
Report: https://www.coherentmarketinsights.com/ongoing-insight/breathing-machines-market-2032
Breathing Machines Market
Regional Insights
On the basis of region, the
global breathing machines market is segmented into North America, Latin
America, Europe, Asia Pacific, Middle East, and Africa. North America is
expected to hold dominant position in the global breathing machines market in
terms of revenue share, owing to increasing number of patients receiving
treatments for respiratory diseases. According to COPD International, in 2016,
around 12 million people in the U.S. were suffering from COPD and an estimated
12 million more were undiagnosed. According to a Centers for Disease Control
and Prevention (CDC) report, it is the fourth leading cause of death in the
U.S.
Asia Pacific breathing machines
market is expected to exhibit highest CAGR, owing to continuously increasing
number of surgeries and respiratory disease burden in the region. For instance,
according to WHO 2017 report, over 90% of COPD deaths occur in low and
middle-income economies. The primary cause of COPD is exposure to tobacco
smoke. Other risk factors include exposure to indoor and outdoor air pollution
and occupational fumes and dusts.
Breathing Machines Market:
Competitive Landscape
Key players operating in the
global breathing machines market include BD, Drager Medical, Fisher &
Paykel, GE Healthcare, Invacare, Maque, Medtronic, OMRON, Philips Healthcare,
Teijin Pharma Resmed, and Weinmann. Key players are focusing on improving
breathing machines by developing energy-efficient power systems and product
features such as lightweight maneuverability, long-lasting components, and
patient-friendly design.
Buy-Now this research
report: https://www.coherentmarketinsights.com/insight/buy-now/2032
About
Coherent Market Insights:
Coherent Market
Insights is a prominent market research and consulting firm offering
action-ready syndicated research reports, custom market analysis, consulting
services, and competitive analysis through various recommendations related to
emerging market trends, technologies, and potential absolute dollar
opportunity.
Contact
Us:
mailto:sales@coherentmarketinsights.com
U.S.
Office:
Name: Mr. Shah
Coherent
Market Insights 1001 4th Ave,
# 3200
Seattle, WA 98154, U.S.
US : +1-206-701-6702
UK : +44-020-8133-4027
JAPAN
: +050-5539-1737
No comments:
Post a Comment